BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale
Jillian Wilhelmina Paulina Bracht, Niki Karachaliou, Trever G. Bivona, Richard B. Lanman, Iris Faull, Rebecca J. Nagy, Ana Drozdowskyj, Jordi Berenguer, Manuel Fernández-Bruno, Miguel Ángel Molina‐Vila, Rafael Rosell
Cancers, 2019
Abstract
This research paper explore the methodology and findings associated with Cancers. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).